Ask HopeStage to review this study with me
Study ID: NCT04513587. We help you review the study, but cannot decide medical eligibility.
UnknownNCT04513587
The Effect and Applicability of CBT-Based Weight Loss Treatment Model in Obese people with Comorbid Depression in Health Care
This study has public registry information in Finland. It focuses on depression.
Depression, Obesity, ...BehavioralFrom 18 Years to 65 Years
Key information made simple
This study is looking at whether a digital support tool can help people with Obesity, Depression, Cognitive Behavioral Therapy, or Weight Loss. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments. Some participants may receive Control instead of the study treatment, and direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a hospital, with sites including Kuopio University Hospital. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: September 1, 2019
- Recruitment status
- Unknown
- Estimated enrollment
- Not clearly listed
- Sponsor
- Kuopio University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioral / psychological / psychosocial
- Study phase
- Not clearly listed
- Locations
- Finland
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04513587
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT04513587. We help you review the study, but cannot decide medical eligibility.
Key study information
- Condition
- Depression, Obesity, ...
- Study status
- Unknown
- Sponsor / lead affiliation
- Kuopio University Hospital
- Location / country
- Finland
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT04513587
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help test a support approach in real life.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Finland.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.
Do I need to want to stop or reduce tobacco use to participate?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Kuopio University Hospital, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The recruitment status is not clearly listed. Check the official registry or contact the study team.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meOther studies you may want to explore next
RecruitingNCT04223115
A Controlled Study of Digitalized Cognitive Behavioral Intervention for Antenatal Depression
This study is recruiting in Finland. It is testing digitalized Cognitive Behavioral Intervention for depression.
RecruitingNCT07076407
A Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
This study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.
RecruitingNCT06390462
Adolescent Interpersonal Counseling in Primary Care
This study is recruiting. It focuses on depression and currently lists participation information in Finland.